BioNTech Soon To Seek Approval For Vaccine For 5-11 Year Olds nova.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nova.ie Daily Mail and Mail on Sunday newspapers.
BERLIN (Reuters) - The launch of German drugmaker BioNTech's vaccine adapted to the Omicron coronavirus variant may be delayed due to a disagreement w.
Drugmakers Pfizer and BioNTech said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under the age of 5 in their clinical trial.
The companies said the vaccine was safe and well-tolerated by the children, and they plan to soon ask global regulators to authorize the shot for the age group.